Table 4

Comparison of BCS patients with prolonged (> 90th percentile) and normal CLT

ParameterProlonged CLTNormal CLTP*
PAI activity, IU/mL 15.5 (6.5-24.6) 5.1 (1.0-13.3) < .001 
t-PA antigen, ng/mL 14.9 (2.5-27.4) 5.9 (1.1-10.8) .003 
TAFI, μg/mL 12.6 (9.4-15.8) 14.0 (10.9-17.0) .713 
Plasmin inhibitor, U/L 0.97 (0.75-1.19) 0.90 (0.74-1.07) .472 
Fibrinogen, g/L 3.1 (2.3-3.9) 2.8 (2.2-3.4) .058 
Factor XIII 83 (58-109) 79 (59-100) .949 
ParameterProlonged CLTNormal CLTP*
PAI activity, IU/mL 15.5 (6.5-24.6) 5.1 (1.0-13.3) < .001 
t-PA antigen, ng/mL 14.9 (2.5-27.4) 5.9 (1.1-10.8) .003 
TAFI, μg/mL 12.6 (9.4-15.8) 14.0 (10.9-17.0) .713 
Plasmin inhibitor, U/L 0.97 (0.75-1.19) 0.90 (0.74-1.07) .472 
Fibrinogen, g/L 3.1 (2.3-3.9) 2.8 (2.2-3.4) .058 
Factor XIII 83 (58-109) 79 (59-100) .949 

Values are stated as median (interquartile range). Prolonged CLT was defined as a CLT above the 90th percentile of the control population (93.1 minutes); patients with a CLT below the 90th percentile were defined as having a normal CLT.

*

Mann-Whitney U test.

or Create an Account

Close Modal
Close Modal